This reciprocal regulatory mechanism acquires particular pathophysiological significance in thyroid-associated ophthalmopathy (TAO), where orbital fibroblasts reside within a TGF-β1-enriched microenvironment. This evidence concerns the gene TGFB1 and Graves ophthalmopathy.